Prognostic MRI features to predict postresection survivals for very early to intermediate stage hepatocellular carcinoma

• DOI: 10.1007/s00330-023-10279-x
• Publication Date: 2023-10-23T05:01:45Z
• Authors: Hanyu Jiang; Yun Qin; Hong Wei; Tianying Zheng; Ting Yang; Yuanan Wu; Chengyu Ding; Victoria Chernyak; Maxime Ronot; Kathryn J. Fowler; Weixia Chen; Mustafa R. Bashir; Bin Song
• Keywords: Neuroradiology; Interventional radiology

Contrast-enhanced MRI can provide individualized prognostic information for hepatocellular carcinoma (HCC). We aimed to investigate the value of features predict early (≤ 2 years)/late (> years) recurrence-free survival (E-RFS and L-RFS, respectively) overall (OS).